Inhibition of caspase-8 activity reduces IFN-γ expression by T cells from Leishmania major infection

Anais da Academia Brasileira de Ciencias

Volumn 80, Issue 1, 2008, Pages 129-136

  Pereira, Wânia F ^a   Guillermo, Landi V C ^a   Ribeiro Gomes, Flávta L ^a   Lopes, Marcela F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Apoptosis; Caspase 8; CD8 T cells; IFN ; Leishmaniasis

Indexed keywords

LEISHMANIA MAJOR; MUS;

EID: 41149133263     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/S0001-37652008000100008     Document Type: Article

References (28)

1. ALAM A, COHEN LY, AOUAD S AND SEKALY RP. 1999. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 190: 1879-1890.
2. ALEXANDER CE, KAYE PM AND ENGWERDA CR. 2001. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice. Eur J Immunol 31: 1199-1210.
3. ALVES NL, VAN LIER RA AND ELDERING E. 2007. Withdrawal symptoms on display: Bcl-2 members under investigation. Trends Immunol 28: 26-32.
4. BELKAID Y, PICCIRILLO CA, MENDEZ S, SHEVACH EM AND SACKS DL. 2002a. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
5. BELKAID Y, VON STEBUT E, MENDEZ S, LIRA R, CALER E, BERTHOLET S, UDEY MC AND SACKS D. 2002b. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol 168: 3992-4000.
6. BERTHO AL, SANTIAGO MA, DA-CRUZ AM AND COUTINHO SG. 2000. Detection of early apoptosis and cell death in T CD4+ and CD8+ cells from lesions of patients with localized cutaneous leishmaniasis. Braz J Med Biol Res 33: 317-325.
7. CHUN HJ ET AL. 2002. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419: 395-399.
8. CORN RA ET AL. 2003. T cell-intrinsic requirement for NF-KB induction in postdifferentiation IFN-γ production and clonal expansion in a Th1 response. J Immunol 171: 1816-1824.
9. DAS G, VOHRA H, RAO K, SAHA B AND MISHRA GC. 1999. Leishmania donovani infection of a susceptible host results in CD4+ T-cell apoptosis and decreased Th1 cytokine production. Scand J Immunol 49: 307-310.
10. DESBARATS J, STONE JE, LIN L, ZAKERI ZF, DAVIS GS, PFEIFFER LM, TITUS RG AND NEWELL MK. 2000. Rapid early onset lymphocyte cell death in mice resistant, but not susceptible to Leishmania major infection. Apoptosis 5: 189-196.
11. DEVADAS S, DAS J, LIU C, ZHANG L, ROBERTS Al, PAN Z, MOORE PA, DAS G AND SHI Y. 2006. Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity 25: 237-247.
12. EIDSMO L, NYLEN S, KHAMESIPOUR A, HEDBLAD MA, CHIODI F AND AKUFFO H. 2005. The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous Leishmaniasis. Am J Pathol 166: 1099-1108.
13. GUILLERMO LV, SILVA EM, RIBEIRO-GOMES FL, DE MEIS J, PEREIRA WF, YAGITA H, DOSREIS GA AND LOPES MF. 2007. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection. J Leukoc Biol 81: 942-951.
14. HERATH S, KROPF P AND MÜLLER I. 2003. Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-γ production by CD4(+) T cells. Parasite Immunol 25: 559-567.
15. HUANG FP, XU D, ESFANDIARI EO, SANDS W, WEI XQ AND LIEW FY. 1998. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production. J Immunol 160: 4143-4147.
16. HUBER M, TIMMS E, MAK TW, ROLLINGHOFF M AND LOHOFF M. 1998. Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect Immun 66: 3968-3970.
17. KENNEDY NJ, KATAOKA T, TSCHOPP J AND BUDD RC. 1999. Caspase activation is required for T cell proliferation. J Exp Med 190: 1891-1896.
18. KRAMMER PH. 2000. CD95's deadly mission in the immune system. Nature 407: 789-795.
19. LENARDO M, CHAN KM, HORNUNG F, MCFARLAND H, SIEGEL R, WANG J AND ZHENG L. 1999. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 17: 221-253.
20. MCMAHON-PRATT D AND ALEXANDER J. 2004. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 201: 206-224.
21. MOHRS M, LEDERMANN B, KOHLER G, DORFMULLER A, GESSNER A AND BROMBACHER F. 1999. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J Immunol 162: 7302-7308.
22. NOBEN-TRAUTH N, PAUL WE AND SACKS DL. 1999. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J Immunol 162: 6132-6140.
23. NOBEN-TRAUTH N, LIRA R, NAGASE H, PAUL WE AND SACKS DL. 2003. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J Immunol 170: 5152-5158.
24. PINHEIRO RO, PINTO EF, BENEDITO AB, LOPES UG AND ROSSI-BERGMANN B. 2004. The T-cell anergy induced by Leishmania amazonensis antigens is related with defective antigen presentation and apoptosis. An Acad Bras Cienc 76: 519-527.
25. SEHRA S, PATEL D, KUSAM S, WANG ZY, CHANG CH AND DENT AL. 2005. A role for caspases in controlling IL-4 expression in T cells. J Immunol 174: 3440-3446.
26. SILVA EM ET AL. 2005. Caspase-8 activity prevents type 2 cytokine responses and is required for protective T cell-mediated immunity against Trypanosoma cruzi infection. J Immunol 174: 6314-6321.
27. SU H, BIDERE N, ZHENG L, CUBRE A, SAKAI K, DALE J, SALMENA L, HAKEM R, STRAUS S AND LENARDO M. 2005. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 307: 1465-1468.
28. WU Z ET AL. 2004. Viral FLIP impairs survival of activated T cells and generation of CD8+ T cell memory. J Immunol 172: 6313-6323.